An Open-label Study Assessing Long-term Safety of DRM04 in Subjects With Primary Axillary Hyperhidrosis
Phase of Trial: Phase III
Latest Information Update: 19 Jan 2017
At a glance
- Drugs Glycopyrrolate (Primary)
- Indications Hyperhidrosis
- Focus Adverse reactions; Registrational
- Acronyms ARIDO
- Sponsors Dermira
- 12 Jan 2017 Status changed from active, no longer recruiting to completed.
- 05 Jan 2017 This trial was completed in Germany (end date: 2016-12-08), according to European Clinical Trials Database.
- 31 Dec 2016 According to a Dermira media release, treatment period of this trial has been completed. Company conducted a preliminary review of this trial.